Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Intra-Articular Steroid Injections: What You Need to Know About Systemic Side Effects and Limits
Dec, 16 2025
Goldenseal and Metformin Interaction Risks for Blood Sugar Control
Dec, 30 2025
Top 6 Alternatives to Cytotec for Ulcer Prevention in 2024
Nov, 17 2024
Natural Ways to Prevent and Treat Cold Sores Fast
Oct, 13 2025
Switching Medications: Proven Strategies to Reduce Side Effects and Avoid Withdrawal
Jan, 31 2026